| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| ARION BANK | 1 | 1 | +2,61 % | ||
| AMAROQ | - | 5 | +8,47 % | ||
| FESTI | - | 4 | - | ||
| JBT MAREL | - | 2 | +1,03 % | ||
| ICELANDAIR GROUP HF | - | - | - | ||
| HAGAR | - | - | - | ||
| SKAGI | - | - | - | ||
| BRIM | - | - | - | ||
| REITIR | - | - | - |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Arion Bank hf.: Arion Bank reaches settlement with the Financial Supervisory Authority | 165 | GlobeNewswire (Europe) | Arion Bank has reached a settlement with the Financial Supervisory Authority of the Central Bank of Iceland (the FSA). The settlement follows a review initiated by the FSA in April 2024 concerning the... ► Artikel lesen | |
| Mo | Kvika banki hf.: Transaction in relation to a share buy-back programme | 4 | GlobeNewswire (USA) | ||
| Fr | H.C. Wainwright reiterates Buy on Oculis stock, $39 target on biomarker data | 4 | Investing.com | ||
| Fr | Icelandair Q3 2026 slides: record revenue, tough winter ahead | 4 | Investing.com | ||
| Do | Icelandair Group hf.: financial results Q3 2026 | 231 | GlobeNewswire (Europe) | Record revenue of USD 655.0 million, up 12% year-on-yearEBIT of USD 120.3 million, improving by USD 45.9 million year-on-year, with the EBIT margin rising to 18.4% from 12.7%Profitability improved despite... ► Artikel lesen | |
| Do | Oculis veröffentlicht Biomarker-Daten aus Phase-2-Studie bei Optikusneuritis | 6 | Investing.com Deutsch | ||
| Do | Oculis reports biomarker data from optic neuritis trial | 3 | Investing.com | ||
| Do | Oculis Holding AG: Oculis Reports New Phase 2 ACUITY Biomarker Data Further Supporting Privosegtor's Neuroprotective Potential in Optic Neuritis | 2 | GlobeNewswire (USA) | ||
| 21.10. | H.C. Wainwright bekräftigt Kaufempfehlung für Oculis nach Fortschritten in klinischer Studie | 5 | Investing.com Deutsch | ||
| 21.10. | Festi hf.: Publication of Q3 2026 results on 28 October 2026 and results presentation on 29 October | 2 | GlobeNewswire (USA) |